
Monday, April 25, 2022 9:47:05 AM

Liked By
Spread the love. Be the first to like this post!
Recent RZLT News
- Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema • GlobeNewswire Inc. • 03/23/2023 08:50:08 PM
- Rezolute to Highlight RZ402 Phase 2 Clinical Program with Leading Clinical Expert • GlobeNewswire Inc. • 03/08/2023 12:00:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 07:42:53 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 06:28:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/13/2023 03:30:24 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/10/2023 09:11:49 PM
- Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress • GlobeNewswire Inc. • 02/10/2023 09:05:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/01/2023 04:52:47 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/13/2023 09:17:11 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/15/2022 09:55:38 PM
- Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular Edema • GlobeNewswire Inc. • 12/15/2022 12:00:00 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 11/10/2022 11:05:48 AM
- Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Rezolute (RZLT) • TipRanks • 11/10/2022 05:50:36 AM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/09/2022 09:28:16 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/09/2022 09:14:31 PM
- Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress • GlobeNewswire Inc. • 11/09/2022 09:05:00 PM
- Rezolute to Present at the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/01/2022 11:00:00 AM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 10/28/2022 08:07:13 PM
- Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting • GlobeNewswire Inc. • 10/20/2022 11:00:00 AM
- Rezolute (RZLT) Receives a Buy from JMP Securities • TipRanks • 09/16/2022 04:25:08 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/15/2022 08:38:39 PM
- Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress • GlobeNewswire Inc. • 09/15/2022 08:05:00 PM
- Rezolute Announces Presentation at the 60th Annual ESPE Meeting • GlobeNewswire Inc. • 09/07/2022 11:00:00 AM
- Rezolute (RZLT) Initiated with a Buy at Canaccord Genuity • TipRanks • 08/03/2022 11:22:16 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 07/01/2022 08:44:37 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM